| Secondary |
| Rheumatoid Arthritis |
40.5% |
| Drug Use For Unknown Indication |
18.0% |
| Product Used For Unknown Indication |
10.6% |
| Psoriatic Arthropathy |
7.2% |
| Dermatomyositis |
3.3% |
| Hypertension |
3.0% |
| Juvenile Arthritis |
2.8% |
| Hodgkin's Disease |
1.9% |
| Ankylosing Spondylitis |
1.4% |
| Pain |
1.4% |
| Depression |
1.3% |
| Musculoskeletal Pain |
1.3% |
| Psoriasis |
1.3% |
| Bronchitis |
0.9% |
| Crohn's Disease |
0.9% |
| Osteoporosis |
0.9% |
| Prophylaxis |
0.9% |
| Breast Cancer |
0.8% |
| Deep Vein Thrombosis |
0.8% |
| Hypercholesterolaemia |
0.8% |
|
| Tuberculosis |
12.5% |
| Pancytopenia |
11.3% |
| Interstitial Lung Disease |
10.0% |
| Cataract |
8.8% |
| Urinary Tract Infection |
8.8% |
| Bacteraemia |
5.0% |
| Thrombocytopenia |
5.0% |
| Weight Decreased |
5.0% |
| Lung Disorder |
3.8% |
| Product Solubility Abnormal |
3.8% |
| Respiratory Distress |
3.8% |
| Abdominal Abscess |
2.5% |
| Breast Cancer |
2.5% |
| Breast Cancer Female |
2.5% |
| Diarrhoea |
2.5% |
| Diverticular Perforation |
2.5% |
| Erysipelas |
2.5% |
| Inflammation |
2.5% |
| Lung Adenocarcinoma |
2.5% |
| Multi-organ Failure |
2.5% |
|
| Concomitant |
| Rheumatoid Arthritis |
43.2% |
| Drug Use For Unknown Indication |
16.8% |
| Product Used For Unknown Indication |
15.3% |
| Psoriatic Arthropathy |
4.2% |
| Psoriasis |
3.2% |
| Osteoporosis |
2.7% |
| Hypertension |
2.1% |
| Ankylosing Spondylitis |
1.6% |
| Crohn's Disease |
1.5% |
| Juvenile Arthritis |
1.5% |
| Histiocytosis Haematophagic |
1.1% |
| Juvenile Idiopathic Arthritis |
1.1% |
| Seronegative Arthritis |
1.0% |
| Pain |
0.9% |
| Hypothyroidism |
0.7% |
| Myasthenia Gravis |
0.7% |
| Premedication |
0.7% |
| Dyslipidaemia |
0.6% |
| Prophylaxis |
0.6% |
| Colitis Ulcerative |
0.5% |
|
| Venoocclusive Disease |
8.0% |
| Weight Decreased |
8.0% |
| Cytolytic Hepatitis |
6.7% |
| Vasculitis |
6.7% |
| Langerhans' Cell Histiocytosis |
5.3% |
| Pneumonia |
5.3% |
| Pyelonephritis |
5.3% |
| Subarachnoid Haemorrhage |
5.3% |
| Vomiting |
5.3% |
| Dyspnoea |
4.0% |
| Malignant Melanoma |
4.0% |
| Neutropenia |
4.0% |
| Phlebitis |
4.0% |
| Pulmonary Embolism |
4.0% |
| Stomatitis |
4.0% |
| Tachycardia |
4.0% |
| Thrombocytopenia |
4.0% |
| Transaminases Increased |
4.0% |
| Urinary Tract Infection |
4.0% |
| Urticaria |
4.0% |
|
| Interacting |
| Rheumatoid Arthritis |
57.1% |
| Product Used For Unknown Indication |
14.3% |
| Psoriatic Arthropathy |
9.5% |
| Candidiasis |
4.8% |
| Collagen Disorder |
4.8% |
| Essential Hypertension |
4.8% |
| Upper Respiratory Tract Infection |
4.8% |
|
| Interstitial Lung Disease |
16.7% |
| Peripheral Sensory Neuropathy |
16.7% |
| Polyarthritis |
16.7% |
| Pulmonary Tuberculosis |
16.7% |
| Stomatitis |
16.7% |
| Thrombocytopenia |
16.7% |
|
